OpenAlex
PricingAboutJobs
Log inGet started
Work

Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of HGS1029, an inhibitor of apoptosis protein (IAP) inhibitor, in patients (Pts) with advanced solid tumors: Results of a phase I study.

HTML

Year: 2011
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2011.29.15_suppl.3008
Authors: B. I. Sikic, S. G. Eckhardt, G. Gallant, H. A. Burris, D. R. Camidge, A. D. Colevas, S. F. Jones, W. A. Messersmith, H. A. Wakelee, H. Li, P. G. Kaminker, S. Morris, J. R. Infante
Language: English

Topic: Cell death mechanisms and regulation
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: IAP inhibitors, advanced solid tumors, dose-limiting toxicity, pharmacokinetics, pharmacodynamics, apoptosis, lymphopenia, neutrophilia, tumor regression, colon cancer, non-small cell lung cancer, adrenocortical carcinoma, three-compartment model, anticancer activity, cytokines
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2589650764
Cites:
Cited by: 44
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security